Personalized Antisense Oligonucleotide for A Single Participant With UBTF Gene Mutation
Personalized Antisense Oligonucleotide for A Single Participant With UBTF Gene Mutation
Active, not recruiting · NCT07588581 · Registry updated 2026-05-15Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Personalized Antisense Oligonucleotide for A Single Participant With UBTF Gene Mutation | Childhood-Onset Neurodegeneration With Brain Atrophy (CONDBA) | Active, not recruiting | Phase 1 / Phase 2 | 2026-05-15 | NCT07588581 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Massachusetts General Hospital | 758 |
| n-Lorem Foundation | 18 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Massachusetts General Hospital | Boston | United States | 1015 |